The resumption of trading for Immix Biopharma shares (IMMX) is significant news for investors and traders, indicating that any previous halts have been lifted. This could lead to increased trading volume and potential volatility as the market reacts. However, without specific reasons for the trading halt or additional context, the direction of the stock price movement remains uncertain, hence a neutral score.